{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:11:49Z","timestamp":1791864709724,"version":"4.3.4"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:sec id=\"ab-hoi230076-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Familial hypercholesterolemia (FH) is a genetic disorder that often results in severely high low-density lipoprotein cholesterol (LDL-C) and high risk of premature coronary heart disease (CHD). However, the impact of FH variants on CHD risk among individuals with moderately elevated LDL-C is not well quantified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess CHD risk associated with FH variants among individuals with moderately (130-189 mg\/dL) and severely (\u2265190 mg\/dL) elevated LDL-C and to quantify excess CHD deaths attributable to FH variants in US adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A total of 21\u202f426 individuals without preexisting CHD from 6 US cohort studies (Atherosclerosis Risk in Communities study, Coronary Artery Risk Development in Young Adults study, Cardiovascular Health Study, Framingham Heart Study Offspring cohort, Jackson Heart Study, and Multi-Ethnic Study of Atherosclerosis) were included, 63 of whom had an FH variant. Data were collected from 1971 to 2018, and the median (IQR) follow-up was 18 (13-28) years. Data were analyzed from March to May 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>LDL-C, cumulative past LDL-C, FH variant status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Cox proportional hazards models estimated associations between FH variants and incident CHD. The Cardiovascular Disease Policy Model projected excess CHD deaths associated with FH variants in US adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 21\u202f426 individuals without preexisting CHD (mean [SD] age 52.1 [15.5] years; 12\u202f041 [56.2%] female), an FH variant was found in 22 individuals with moderately elevated LDL-C (0.3%) and in 33 individuals with severely elevated LDL-C (2.5%). The adjusted hazard ratios for incident CHD comparing those with and without FH variants were 2.9 (95% CI, 1.4-6.0) and 2.6 (95% CI, 1.4-4.9) among individuals with moderately and severely elevated LDL-C, respectively. The association between FH variants and CHD was slightly attenuated when further adjusting for baseline LDL-C level, whereas the association was no longer statistically significant after adjusting for cumulative past LDL-C exposure. Among US adults 20 years and older with no history of CHD and LDL-C 130 mg\/dL or higher, more than 417\u202f000 carry an FH variant and were projected to experience more than 12\u202f000 excess CHD deaths in those with moderately elevated LDL-C and 15\u202f000 in those with severely elevated LDL-C compared with individuals without an FH variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-hoi230076-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this pooled cohort study, the presence of FH variants was associated with a 2-fold higher CHD risk, even when LDL-C was only moderately elevated. The increased CHD risk appeared to be largely explained by the higher cumulative LDL-C exposure in individuals with an FH variant compared to those without. Further research is needed to assess the value of adding genetic testing to traditional phenotypic FH screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamacardio.2023.5366","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T11:33:16Z","timestamp":1706700796000},"page":"263","source":"Crossref","is-referenced-by-count":31,"title":["Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol"],"prefix":"10.1001","volume":"9","author":[{"given":"Yiyi","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of General Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Dron","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge"},{"name":"Center for Genomic Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon K.","family":"Bellows","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Khera","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine, Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi P.","family":"Balte","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Oelsner","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Samir","family":"Amr","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Laboratory for Molecular Medicine, Personalized Medicine, Mass General Brigham, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Lebo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Laboratory for Molecular Medicine, Personalized Medicine, Mass General Brigham, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nagy","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Medicine, Personalized Medicine, Mass General Brigham, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina M.","family":"Peloso","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Natarajan","sequence":"additional","affiliation":[{"name":"Cardiovascular Disease Initiative, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge"},{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome I.","family":"Rotter","sequence":"additional","affiliation":[{"name":"The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristen","family":"Willer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor"},{"name":"Department of Human Genetics, University of Michigan, Ann Arbor"},{"name":"Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boerwinkle","sequence":"additional","affiliation":[{"name":"Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M.","family":"Ballantyne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Lutsey","sequence":"additional","affiliation":[{"name":"Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fornage","sequence":"additional","affiliation":[{"name":"The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M.","family":"Lloyd-Jones","sequence":"additional","affiliation":[{"name":"Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Hou","sequence":"additional","affiliation":[{"name":"Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle"},{"name":"Department of Epidemiology, University of Washington, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Bis","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Floyd","sequence":"additional","affiliation":[{"name":"Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle"},{"name":"Department of Epidemiology, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[{"name":"The Framingham Heart Study, Framingham, Massachusetts"},{"name":"Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Heard-Costa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April P.","family":"Carson","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Mississippi Medical Center, Jackson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[{"name":"Center for Public Health Genomics, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[{"name":"The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv S.","family":"Kazi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harvard Medical School, Boston, Massachusetts"},{"name":"Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"de Ferranti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[{"name":"Division of General Medicine, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"22","key":"hoi230076r1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association.","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"hoi230076r2","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).","volume":"133","author":"de Ferranti","year":"2016","journal-title":"Circulation"},{"issue":"25","key":"hoi230076r3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"20","key":"hoi230076r4","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/eurheartj\/ehx136","article-title":"Genetic testing for familial hypercholesterolaemia is essential in individuals with high LDL cholesterol: who does it in the world?","volume":"38","author":"Nordestgaard","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi230076r5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"hoi230076r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2023.100580","article-title":"Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population.","volume":"15","author":"Ray","year":"2023","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"hoi230076r7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-2004-822987","article-title":"Advanced method for the identification of patients with inherited hypercholesterolemia.","volume":"4","author":"Defesche","year":"2004","journal-title":"Semin Vasc Med"},{"issue":"6807","key":"hoi230076r8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.","volume":"303","year":"1991","journal-title":"BMJ"},{"issue":"6","key":"hoi230076r9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC Scientific Expert Panel.","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6319","key":"hoi230076r10","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf7000","article-title":"Genetic identification of familial hypercholesterolemia within a single US health care system.","volume":"354","author":"Abul-Husn","year":"2016","journal-title":"Science"},{"issue":"22","key":"hoi230076r11","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia.","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi230076r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3959","article-title":"Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and lynch syndrome with disease risk in adults according to family history.","volume":"3","author":"Patel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"20","key":"hoi230076r13","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.123.064168","article-title":"Association of severe hypercholesterolemia and familial hypercholesterolemia genotype with risk of coronary heart disease.","volume":"147","author":"Zhang","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"hoi230076r14","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators.","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"11","key":"hoi230076r15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0895-4356(88)90080-7","article-title":"CARDIA: study design, recruitment, and some characteristics of the examined subjects.","volume":"41","author":"Friedman","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"hoi230076r16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/1047-2797(91)90005-W","article-title":"The Cardiovascular Health Study: design and rationale.","volume":"1","author":"Fried","year":"1991","journal-title":"Ann Epidemiol"},{"issue":"4","key":"hoi230076r17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0091-7435(75)90037-7","article-title":"The Framingham Offspring Study. design and preliminary data.","volume":"4","author":"Feinleib","year":"1975","journal-title":"Prev Med"},{"issue":"3","key":"hoi230076r18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0002-9629(15)40495-1","article-title":"Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women.","volume":"317","author":"Sempos","year":"1999","journal-title":"Am J Med Sci"},{"issue":"4 Suppl 6","key":"hoi230076r19","article-title":"Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study.","volume":"15","author":"Taylor","year":"2005","journal-title":"Ethn Dis"},{"issue":"9","key":"hoi230076r20","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design.","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"11","key":"hoi230076r21","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/aje\/kwy139","article-title":"Harmonization of respiratory data from 9 US population-based cohorts: the NHLBI Pooled Cohorts Study.","volume":"187","author":"Oelsner","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"5","key":"hoi230076r22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns.","volume":"129","author":"Frank","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"hoi230076r23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018263","article-title":"Patients with LDLR and PCSK9 gene variants experienced higher incidence of cardiovascular outcomes in heterozygous familial hypercholesterolemia.","volume":"10","author":"Doi","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"24","key":"hoi230076r24","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1161\/CIRCULATIONAHA.120.051683","article-title":"Cost-effectiveness of hypertension treatment by pharmacists in Black barbershops.","volume":"143","author":"Bryant","year":"2021","journal-title":"Circulation"},{"issue":"20","key":"hoi230076r25","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.jacc.2021.08.065","article-title":"Cost-effectiveness of lipid-lowering treatments in young adults.","volume":"78","author":"Kohli-Lynch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"hoi230076r26","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.117.032321","article-title":"Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999-2014).","volume":"137","author":"Bucholz","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"hoi230076r27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype.","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"hoi230076r28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.025192","article-title":"Estimated yield of screening for heterozygous familial hypercholesterolemia with and without genetic testing in US adults.","volume":"11","author":"Bellows","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"hoi230076r29","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.jacl.2016.08.001","article-title":"Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study.","volume":"10","author":"Safarova","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"5","key":"hoi230076r30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.","volume":"10","author":"Ahmad","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"4","key":"hoi230076r31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/jama.2017.8543","article-title":"Cascade screening for familial hypercholesterolemia and the use of genetic testing.","volume":"318","author":"Knowles","year":"2017","journal-title":"JAMA"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2814372\/jamacardiology_zhang_2024_oi_230076_1710221270.95308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:21:42Z","timestamp":1710328902000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2814372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.5366","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}